Combination of er.alpha.+ ligands and histone deacetylase...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/165 (2006.01) A61K 31/335 (2006.01) A61K 31/44 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2669675

The present embodiments relate to compositions and methods of treatment of cancer. More particularly, the present embodiments relate to the combination of an ER.alpha.+ ligand with an HDACi for the treatment of cancer, methods of treating cancer and pharmaceutical compositions for treating cancer.

Compositions et procédés de traitement du cancer. Les modes de réalisation de cette invention concernent plus particulièrement l'association d'un ligand de ER.alpha.+ et d'un inhibiteur de HDAC dans le traitement du cancer, des procédés de traitement du cancer et des compositions pharmaceutiques permettant de traiter le cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of er.alpha.+ ligands and histone deacetylase... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of er.alpha.+ ligands and histone deacetylase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of er.alpha.+ ligands and histone deacetylase... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1356255

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.